URGN Since 2017 Annualized Return and Average Annual Return

URGN Average Annual Return Chart Since 2017
Growth of $10,000.00
Without Dividends Reinvested Into URGN

Also see:
• URGN stock yearly return 2018
• URGN stock yearly return 2019
• URGN stock yearly return 2020
• URGN stock yearly return 2021
• URGN stock yearly return 2022
• URGN stock yearly return 2023
• URGN stock yearly return 2024
• URGN stock yearly return 2025
• URGN YTD return
Average Annual Return Benchmarks
Compare URGN average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
URGN Share Performance
URGN Average Annual Return Table Since 2017
Start date: 05/05/2017
End date: 09/11/2026
Start price/share: $14.00
End price/share: $42.31
Dividends collected/share: $0.00
Total return: 202.21%
URGN Average Annual Return: 12.54%
Starting investment: $10,000.00
Ending investment: $30,211.79
Years: 9.36


URGN average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About UroGen Pharma Ltd
UroGen Pharma Ltd. Is an Israel-based biopharmaceutical company. Co. is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. The URGN average annual return since 2017 is shown above.

The Average Annual Return on the URGN average annual return since 2017 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether URGN average annual return since 2017 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the URGN average annual return calculation with any dividends reinvested as applicable (on ex-dates).
URGN Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree URGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!
Average Annual Return Peers
 

URGN Average Annual Return Since 2017 | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.